Integrated System of Measures for the Treatment of Papillomavirus Infection

Abstract

this article attempts to reveal the main reasons for the creation of a comprehensive system of measures for the treatment of human papillomavirus infection (PVI) and a significant reduction in the recurrence of the disease. To carry out scientific work, the author found that HPV type 16 among patients with cervical cancer is detected in 68.3% of cases, HPV type 18 - in 11.7% of cases. A comparative evaluation of the effectiveness of monotherapy and combined treatment of PVI was carried out in 98 patients (age 25–37 years) with localization of tumor elements in the external genital area. Group I (52 people) consisted of patients who were treated only with the method of laser therapy (copper vapor laser 578 nm "Yakhroma-Med", which selectively affects the pathological tissue). Group II (46 people) consisted of patients who received combined treatment: laser destruction, epithelialization occurred within 5–7 days, after which Keravort cream (5% imiquimod) was administered externally, which was applied to the entire surface of the skin where condylomas were localized, capturing visibly healthy skin 1 cm in diameter at night 3 times a week for 4-8 weeks. The problem in question is still little studied, therefore, requires more thorough research